Vancouver, British Columbia–(Newsfile Corp. – June 23, 2026) – The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the “Company” or “BPC”), a publicly traded wellness company focused on advanced peptide formulations, today announced it has been awarded LegitScript Healthcare Merchant Certification – an independent, third-party seal recognizing the Company’s compliance, transparency, and consumer-safety standards. The certification is recognized by Visa, Mastercard, Google, Microsoft, and Meta, many of which require it before a healthcare business can process payments or advertise on their platforms.
This excerpt is quoted from the original release. Read the full announcement on Newsfile Corp.
Brief Summary
The Precision Peptide Company has achieved an important milestone by earning the LegitScript Healthcare Merchant Certification. This independent certification signifies the Company’s commitment to strict compliance and transparency in the healthcare sector. The certification is crucial as it allows BPC to participate in advertising opportunities and payment processing across leading platforms including Visa, Mastercard, Google, Microsoft, and Meta.
- Enhanced credibility in the competitive health marketplace.
- Access to payment processing from major financial platforms.
- Adherence to consumer safety standards.
Why it matters: This certification will strengthen the Company’s market position, making it more attractive to investors and customers alike.
Read the Full Article
This is a summary of the press release. For the complete article and any additional details, please visit the original source.
Attribution: Original press release by Newsfile Corp on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.